To reach these goals, lung function tests have to be performed from early infancy and have to reflect the whole spectrum of pathological and functional changes in CF lungs. Unfortunately, routine lung function tests do not meet these criteria. Flow-volume curves can be very helpful in the treatment of CF patients because they may reveal major changes such as obstruction of peripheral bronchi (decrease of forced expiratory volume in 1 s (FEV1)) and decrease of functional lung volume (decrease of forced vital capacity (FVC)). However, flow volume curves cannot be performed in children under the age of about 6 years. In addition, they do not inform us about the whole spectrum of changes in CF lungs. For example, they provide no information about total lung capacity, air trapping, ventilation perfusion inequalities or gas exchange, all of which are abnormalities frequently observed in CF.
In this review we summarize the most important pathophysiological changes in the lungs of CF Lungs of infants who died from meconium ileus are sometimes microscopically normal, but in most instances mucosal and submucosal gland hypertrophy and duct obstruction by accumulation of mucin are found1. These changes are also observed in children without evidence of infection. Once respiratory tract infections commence, the airways become filled with thick mucopurulent material2. Plugging of bronchi and bronchioli and compression of bronchi by enlarged lymph nodes can result in lobar collapse. Repeated infections cause ulcerative bronchitis which commonly leads to irreversible dilation of the bronchial walls with resultant bronchiectasis. These findings have been observed in most children with CF at the age of 6 months. Endobronchial abscesses produce cavities within the lung parenchyma, resulting in fibrous scarring. This causes further obliteration of bronchioli and small bronchi, which can lead to pulmonary hyperinflation or collapse3. Pulmonary parenchymal necrosis due to repeated pulmonary infections can also cause pneumatoceles, especially in superior and subpleural areas. Thus, the earliest disease in the lungs of CF patients is localized in the small airways, followed by abnormalities in lung parenchyma and larger 4 airways4.
LUNG FUNCTION TESTS IN INFANTS AND YOUNG CHILDREN WITH CYSTIC FIBROSIS
To detect early pathophysiological changes in the lungs, lung function testing in infancy might be helpful. In general, measurement of lung function in infants and young children is technically complicated. Sedation of the child is often required and reference values for lung function tests in infants are often lacking. For these reasons, lung function testing is confined to research laboratories. Moreover, literature on lung function data in young children largely deals with the topic of asthma and recurrent wheezing, while experience in CF is scarce. We will discuss the lung function tests that have been used in young children with CF.
Squeeze jacket technique in cystic fibrosis
In this technique, the infant is wrapped in an inflatable jacket. After sedation the child breathes quietly in a facemask attached to a pneumotachograph. The jacket is rapidly inflated at the end of a spontaneous inspiration, and the thorax is 'squeezed'. During this squeeze manoeuvre, a flow-volume curve can be recorded (Figure 1 ). To obtain a maximal flow-volume curve the test is repeated at increasing pressures (usually 20-80 cm H20) until the maximal flow is reported. The maximal flow at functional residual capacity (VmaxFRC) level can be used as a parameter of airflow obstruction5-7. Although the applicability of squeeze jacket techniques offers great potential in evaluating infants' pulmonary function, several technical problems need to be addressed. It is difficult to find the optimal squeeze-pressure in individual infants8-1 1. The intra-subject variability of repeated measurements of VmaxFRC in one infant is rather high when compared with the repeatability of, for example, FEVy in older children6. There is a lack of reference values, and data depend on technical differences in the apparatus of different authors6'12. Improper positioning of the head and nasal compression can result in upper airway narrowing. Reflex inspiratory effort in response to chest compression can disturb the recording of a maximal flow-volume loop13.
There is also lack of consensus about standardization of measurement conditions (e.g. arms of the infant inside or outside the jacket)8.
Tepper and coworkers studied bronchial obstruction, using VmaxFRC, in 12 CF infants with pulmonary symptoms and compared them with 13 CF infants with only meconium ileus or failure to thrive14. They found significantly decreased V axFRC values in those with pulmonary symptoms, suggesting that peripheral airway obstruction plays a central role in pulmonary symptoms at this age. No differences were found between flow values in CF infants without pulmonary symptoms and normal controls. These findings were consistent with reports of normal pulmonary anatomy in newborns with CF dying from meconium ileus1.
Beardsmore also measured VmaxFRC values in CF infantsl5. She could not detect any relationship between decrease of VmaxFRC in infancy and parameters of airflow obstruction at the age of 6 years. These findings showed that in infancy lung function can be quite normal, with deterioration in later life. They also showed that airflow obstruction at this age can be reversible and that airflow obstruction in infancy does not predict bad lung function during later life.
Whole body plethysmography in cystic fibrosis
In whole body plethysmography, the patient is placed in a sealed box and breathes through a mouthpiece with shutter. 
Vma.FRC is low in patients with airway obstruction
When the patient breathes quietly against a closed shutter, pressure changes in the mouth (Pmouth) can be measured, while the thoracic gas volume (TGV) is unchanged. The breathing manoeuvres result in pressure changes in the box (Pox), which has a fixed, known, volume (Vbox). Using the equation (Pmouth*TGV=Pbox*Vbox) the lung volume can be computed1621. Increased values in patients with CF can correspond with hyperinflation, secondary to airway obstruction. The expensive equipment and technical problems such as correction to body temperature ambient pressure saturated conditions limit use of this technique to research laboratory settings and make it susceptible to misinterpretations and miscalculations, especially in infants22,23
Beardsmore found a significant correlation between TGV in infants with CF and their TGV measured at school age1s. Godfrey and coworkers found no increase of TGV in both symptomatic and asymptomatic infants with CF24. However, they found signs of airflow obstruction in all symptomatic and in half of the asymptomatic infants, suggesting that subclinical lung function abnormalities do exist in some children.
Distribution of ventilation and oxygen saturation in cystic fibrosis
The uniformity of the distribution of ventilation can be assessed by calculating a mixing index (MI) from a helium equilibration curve. In this technique, the patient breathes into a closed circuit with a water-sealed spirometer, which is filled with a known concentration of helium. During breathing the helium concentration will equilibrate over the Su p pleme nt No 3 7 Volume 92 1 9 9 9 JOURNAL OF THE ROYAL SOCIETY OF MEDICINE Supplement No. 37 Volume 92 1 999 spirometer and the lungs of the patient. Because of the inertia of helium, this gas will not be resorbed by the patient and, after some time, a final constant helium concentration will be reached in the patient-spirometer system. The MI can be calculated as the ratio of the predicted number of breaths to the actual number of breaths needed to reach 90% of the final helium concentration. The lower the value of MI, the less homogeneous the distribution of ventilation.
In the study of Tepper and coworkers, decreased values of MI were found in CF infants with failure to thrive compared to normal controls14. This decrease was more evident in those with pulmonary symptoms, but was also present in infants with CF who had no pulmonary symptoms.
Perhaps the most simple lung function test in CF infants is transcutaneous measurement of oxygen saturation of haemoglobin (SaO2). Kraemer and Schdni showed in children with CF that oxygen tension in arterial blood is closely related to the degree of ventilation inequality as measured with a mixing index25. Low transcutaneous SaO2 levels are, therefore, suggestive of ventilation inequalities in young children. The children with low MIs in the Tepper study also had low SaO2 levels14. In clinical practice, simple measurement of SaO2 is an important lung function test.
Tidal breathing flow pattern analysis
Several workers have analysed tidal expiratory flow patterns to detect and quantify airway obstruction. In adult patients with airflow obstruction, Morris and Lane described a rapid rise of tidal expiratory flow to the maximum value26. They recorded tidal breathing airflow cycles and measured the time needed to reach maximal expiratory flow (tPTEF) as a percentage of the total expiratory time (tE). The ratio of these time values (tPTEF/tE) correlated with other spirometric parameters of airway obstruction. Morgan and coworkers reported that infants with bronchopulmonary dysplasia had significantly lower values of tPTEF/tE than normal infants27. Several studies showed tPTEF/tE measurements to be useful in assessment of airway patency in healthy newborns and infants with wheezing respiratory illnesses28-31. In schoolchildren, a good correlation was shown between tidal expiratory flow patterns and forced spirometric results32.
In a study in children aged 3 years and over we described significantly lower values of tPTEF/tE in children with CF compared to normal controls33. Figure 2 shows the tidal expiratory flow patterns in a healthy child and in a child with CF. No changes in the ratio were found after administration of a bronchodilator, which was in contrast to the findings in children with asthma. The tPTEF/tE ratio was parameters of airway obstruction. These data suggest that the ratio tPTEF/tE can be an easy parameter of lower airway obstruction in young children with CF.
LUNG FUNCTION TESTS IN OLDER CHILDREN WITH CYSTIC FIBROSIS
In children from the age of about 6 years, most lung function tests can be performed as in adults. Flow volume measurement and measurements of mechanical properties and volume of the respiratory system can be performed. All lung function tests can be performed as described for infants and young children (except squeeze jacket techniques). Because most children can cooperate with the tests at this age, repeatability and reliability of tests are better. From the point of view of lung function tests as a reflection of the pathophysiological changes in the lung of CF patients, two methods are most important: repeated measurements of flow-volume curves, and measurements of thoracic gas volume with use of the whole body plethysmograph.
Repeated measurements of flow-volume curves in cystic fibrosis
Flow-volume measurements during forced expiration can be extremely helpful in decision-making in CF treatment. The practical application and interpretation of this test is discussed extensively in the preceding paper. 
Measurement of thoracic gas volume in cystic fibrosis
As in infants and young children, thoracic gas volume can be measured in older children with CF using the whole body plethysmograph. Measurement of lung volume gives the clinician more insight into the pathology of the CF lung and into the severity of the disease. As pointed out above, the course of lung function in CF is characterized by gradual decline of vital capacity. However, measurements of thoracic gas volume show that, in general, patients with CF do not develop restrictive lung disease (the strict definition of restrictive lung disease is a decreased total lung capacity (TLC) and not merely a decreased vital capacity). Figure 5 shows consecutive values of TLC in the same population as in Figures 3 and 4 . This shows that TLC does not decrease during follow-up, but even shows a slight increase. Decrease of vital capacity (FVC) with stable TLC can only be explained by an increase of residual volume (RV). Measurements of RV in the body plethysmograph showed an annual rate of change of RV of +2.65% of TLC. Therefore, next to decreases in FEV1 and FVC, increases in RV, expressed as percentage of TLC, is an additional parameter of deteriorating lung condition in CF. Figure 6 shows the combined features in our patient group: bronchial obstruction (FE1) is closely related to airtrapping (RV%TLC). Especially in patients with severe Figure 4 Consecutive measurements of forced vital capacity during follow-up of 11 patients with cystic fibrosis. The line represents the mean linear regression curves of the measurements airflow obstruction (low FEV1 values), the changes in airtrapping (RV%TLC) become more pronounced. In this way, the pathophysiological changes in CF can be figured out by pulmonary function tests. When the patient grows up he or she gradually shifts on the X-axis from the right to the left ( Figure 6 ). Progressive airtrapping results in inequality of ventilation and concomitant inhibition of adequate gas exchange. Progressive loss of vital capacity will result in ventilatory insufficiency and eventually death of the patient.
CONCLUSIONS
In summary, lung function tests during early childhood reflect the pathophysiological changes in the lungs of patients with CF. They show signs of peripheral airway obstruction and ventilation inequalities, with secondary disturbances of oxygen saturation. Most studies show that lung function can be completely normal in asymptomatic children. However, children have been described with evident abnormalities in lung function but without any clinical suspicion of pulmonary pathology. Maybe these Supplement No 37 Volume 92 1 9 9 9 1 9 9 9 160 140 _ 120 . 10 children can benefit from lung function testing in infancy, when earlier diagnosis might lead to intervention and a better outcome. Although these data are promising, a lot of technical difficulties have to be overcome, and the effects of treatment on pulmonary function have to be documented before routine lung function testing in all infants and young children with CF can be recommended. In older children, lung function tests can be performed more or less as in adults. Flow-volume measurements during forced expiration can be extremely helpful in decision-making in CF treatment. In older children, regular check-up of FEV1 and FVC is strongly recommended because these measurements show the clinician the course of pathophysiological changes in CF in individuals and groups of patients. When flow-volume measurements are combined with measurements of RV and TLC in the body plethysmograph, the pulmonary pathophysiological changes in CF can be more clearly defined. Particularly in patients with severe airway obstruction, more comprehensive lung function tests can be helpful to monitor disease. 
